|
Volumn 20, Issue 3, 2010, Pages 1100-1105
|
Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells
|
Author keywords
6 4 Fluoro 3 (piperazin 1 ylcarbonyl)benzyl 4,5 dimethylpyridazin 3(2H) ones; Anticancer agents; BRCA1 deficient cancer cells; Coupling reactions; PARP 1 inhibitor; Pharmacokinetic properties; SAR exploration
|
Indexed keywords
5 [(4,5 DIMETHYL 6 OXO 1,6 DIHYDROPYRIDAZIN 3 YL)METHYL] 2 FLUOROBENZOIC ACID;
6 [4 FLUORO 3 (PIPERAZIN 1 YLCARBONYL)BENZYL] 4,5 DIMETHYLPYRIDAZIN 3(2H) ONE;
6 [4 FLUORO 3 [[4 (2 METHYLPROLYL)PIPERAZIN 1 YL]CARBONYL]BENZYL] 4,5 DIMETHYL PYRIDAZIN 3(2H) ONE;
ANTINEOPLASTIC AGENT;
BRCA1 PROTEIN;
CYTOCHROME P450;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
PIPERAZINE DERIVATIVE;
POTASSIUM CHANNEL HERG;
PYRIDAZINE DERIVATIVE;
UNCLASSIFIED DRUG;
BRCA1 PROTEIN, HUMAN;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
PARP1 PROTEIN, HUMAN;
ANIMAL CELL;
ANIMAL CELL CULTURE;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG CLEARANCE;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG IDENTIFICATION;
HUMAN;
HUMAN CELL;
HUMAN CELL CULTURE;
LIVER MICROSOME;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
URINARY EXCRETION;
WILD TYPE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
COMPARATIVE STUDY;
DEFICIENCY;
DRUG EFFECTS;
ENZYMOLOGY;
GENETICS;
HELA CELL LINE;
METABOLISM;
SYNTHESIS;
RATTUS;
ANIMALS;
BRCA1 PROTEIN;
HELA CELLS;
HUMANS;
MICROSOMES, LIVER;
PIPERAZINES;
POLY(ADP-RIBOSE) POLYMERASES;
PYRIDAZINES;
RATS;
|
EID: 74049143159
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.11.087 Document Type: Article |
Times cited : (19)
|
References (17)
|